![Mats Lindskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats Lindskog
Direktor/Vorstandsmitglied bei
ONCOZENGE AB
Profil
Mats Lindskog currently works at OncoZenge AB, as Independent Director from 2025.
Mr. Lindskog also formerly worked at ACAP Invest AB, as Chief Executive Officer in 2012.
Mr. Lindskog received his graduate degree and doctorate degree from Royal Institute of Technology and undergraduate degree from Blekinge Tekniska Högskola.
Aktive Positionen von Mats Lindskog
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOZENGE AB | Direktor/Vorstandsmitglied | 01.01.2025 |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mats Lindskog
| Unternehmen | Position | Ende |
|---|---|---|
| WNTRESEARCH AB | Direktor/Vorstandsmitglied | - |
| ACAP INVEST AB | Vorstandsvorsitzender | - |
Ausbildung von Mats Lindskog
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
ACAP Invest AB
 ACAP Invest AB Investment Trusts/Mutual FundsMiscellaneous Provides investment services | Miscellaneous |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Blekinge Tekniska Högskola
 Blekinge Tekniska Högskola Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
